Literature DB >> 27015740

Towards a bioethics of innovation.

Wendy Lipworth1, Renata Axler2.   

Abstract

In recent years, it has become almost axiomatic that biomedical research and clinical practice should be 'innovative'-that is, that they should be always evolving and directed towards the production, translation and implementation of new technologies and practices. While this drive towards innovation in biomedicine might be beneficial, it also raises serious moral, legal, economic and sociopolitical questions that require further scrutiny. In this article, we argue that biomedical innovation needs to be accompanied by a dedicated 'bioethics of innovation' that attends systematically to the goals, process and outcomes of biomedical innovation as objects of critical inquiry. Using the example of personalised or precision medicine, we then suggest a preliminary framework for a bioethics of innovation, based on the research policy initiative of 'Responsible Innovation'. We invite and encourage critiques of this framework and hope that this will provoke a challenging and enriching new bioethical discourse. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Applied and Professional Ethics; Public Policy; Technology/Risk Assessment

Mesh:

Year:  2016        PMID: 27015740     DOI: 10.1136/medethics-2015-103048

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Public trust and 'ethics review' as a commodity: the case of Genomics England Limited and the UK's 100,000 genomes project.

Authors:  Gabrielle Natalie Samuel; Bobbie Farsides
Journal:  Med Health Care Philos       Date:  2018-06

2.  Regulating the stem cell industry: needs and responsibilities.

Authors:  Tsung-Ling Lee; Tamra Lysaght; Wendy Lipworth; Tereza Hendl; Ian Kerridge; Megan Munsie; Cameron Stewart
Journal:  Bull World Health Organ       Date:  2017-07-01       Impact factor: 9.408

3.  Governance of research consortia: challenges of implementing Responsible Research and Innovation within Europe.

Authors:  Michael Morrison; Miranda Mourby; Heather Gowans; Sarah Coy; Jane Kaye
Journal:  Life Sci Soc Policy       Date:  2020-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.